Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
254.19
+12.73 (5.27%)
At close: Nov 6, 2026, 4:00 PM EST
256.90
+2.71 (1.07%)
After-hours: Nov 6, 2026, 7:59 PM EST

Moderna Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
1,3131453896781,0161421089661,8622411672,8111,8313441,8625,0843,3644,7496,0667,211
Revenue Growth
29.23%2.11%260.19%-29.81%-45.43%-41.08%-35.33%-65.64%1.69%-29.94%-91.03%-44.71%-45.57%-92.76%-69.30%-29.50%-32.30%9.07%213.16%1162.87%
Gross Profit
418-593-337-5498-677-838-895211-1,095-992476-1,570-1,535-611,9551,4442,6584,4955,611
Operating Income
136-809-510-857-260-907-1,050-1,246-70-1,363-1,2666-2,012-1,867-3661,5801,1662,4474,2275,410
Net Income
162-782-1,343-826-200-825-971-1,12013-1,279-1,175217-3,630-1,380791,4651,0432,1973,6574,868
Earnings Per Share
0.38-1.96-3.40-2.11-0.51-2.13-2.52-2.910.03-3.33-3.080.54-9.53-3.620.193.642.535.248.5811.29
EPS Growth
------------85.11%---97.79%-67.78%-67.14%-18.88%202.11%-

Revenue by Segment

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Product Sales
1,27394352645973114869381,8201841672,7931,7572931,8284,8593,1204,5315,9256,935
Grant
12-2145110720--2442824-65144183126262
Collaboration
8155174113287-20302310290100351514
Licensing and Royalty
-3--12285730----------
Stand-Ready Manufacturing
31313231201712-------------
Revenue (Total)
1,3131453896781,0161421089661,8622411672,8111,8313441,8625,0843,3644,7496,0667,211

Cash & Debt

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Investments
7,9766,9107,4568,1356,6477,5058,3939,5199,20210,81412,16113,28112,84614,56416,36518,22017,00318,05919,28617,570
Total Debt
4,2291,2871,2981,3057347417457471,3551,2691,2371,2431,4551,1681,1081,2001,261887947916
Net Cash (Debt)
3,7475,6236,1586,8305,9136,7647,6488,7727,8479,54510,92412,03811,39113,39615,25717,02015,74217,17218,33916,654
Net Cash Growth
-36.63%-16.87%-19.48%-22.14%-24.65%-29.14%-29.99%-27.13%-31.11%-28.75%-28.40%-29.27%-27.64%-21.99%-16.81%2.20%89.14%132.46%145.96%232.41%
Net Cash Per Share
8.7114.1315.5917.4215.1617.4319.8122.7819.6724.8628.6030.4829.9035.1637.6742.0238.2140.9843.0538.64

Cash Flow & CapEx

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Cash Flow
-1,559-526-630930-847-919-1,037825-1,566-1,274-989622-1,600-915-1,2251,6622523042,7633,310
Capital Expenditures
-47-37-62-39-33-3-117-522-151-182-196-220-140-234-113-92-89-87-132-120
Free Cash Flow
-1,606-563-692891-880-922-1,154303-1,717-1,456-1,185402-1,740-1,149-1,3381,5701632172,6313,190
Free Cash Flow Growth
---194.06%----24.63%----74.39%----50.78%-94.87%-94.62%-10.39%157.26%

Margins

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Gross Margin
31.84%--86.63%-80.97%0.79%---92.65%11.33%--16.93%-85.75%--3.28%38.45%42.93%55.97%74.10%77.81%
Operating Margin
10.36%-557.93%-131.11%-126.40%-25.59%-638.73%-972.22%-128.99%-3.76%-565.56%-758.08%0.21%-109.89%-542.73%-19.66%31.08%34.66%51.53%69.68%75.02%
Pretax Margin
13.02%-528.97%-342.93%-117.85%-18.41%-576.06%-892.59%-122.57%1.13%-530.71%-697.60%2.49%-106.94%-508.43%-16.38%32.55%36.18%52.10%69.72%75.02%
Profit Margin
12.34%-539.31%-345.24%-121.83%-19.68%-580.99%-899.07%-115.94%0.70%-530.71%-703.59%7.72%-198.25%-401.16%4.24%28.82%31.00%46.26%60.29%67.51%
FCF Margin
-122.31%-388.28%-177.89%131.42%-86.61%-649.30%-1068.52%31.37%-92.21%-604.15%-709.58%14.30%-95.03%-334.01%-71.86%30.88%4.84%4.57%43.37%44.24%

Valuation

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
--------------12.388.253.934.044.748.44
Forward PE
31.9431.9431.9431.9431.9431.9431.9431.9431.9431.9431.9431.9431.9431.9431.9437.047.676.536.278.08
P/FCF Ratio
---------------15.067.466.175.337.72
PS Ratio
30.4512.479.065.934.503.473.454.955.069.017.925.544.314.353.933.582.162.473.075.58